SlideShare uma empresa Scribd logo
1 de 17
6. Reporting
Communicable
Disease:
Dr. Ayub Abdulkadir (Dr. Alto)
Medical Ethics
Reportable illness:
• Physicians and laboratories are mandated to report
a number of medical illnesses. The main purpose in
reporting illnesses is both epidemiologic as well as
to interrupt the spread of certain communicable
diseases.
• The illnesses that are always reportable include:
1. AIDS.
2. Syphilis.
3. Tuberculosis.
4. Gonorrhea.
• and all of the childhood diseases such as:
1. Measles.
2. Mumps.
3. Rubella.
4. Pertussis.
• These diseases are reportable by somebody,
not necessarily the physician.
• Physicians are always legally protected for
participating in partner notification.
• In general, the health department performs
the majority of contact-tracing events as well as
notifying those that have been in close contact of
the possibility of infection.
• Partner notification exists for diseases such as
HIV/AIDS, syphilis, gonorrhea, and tuberculosis.
• In addition, the health department can incarcerate
(jail) patients with tuberculosis to prevent the
spread of disease.
• If a patient won’t tell his or her partner, then you
must answer that you must follow your duty to
report.
• If the source patient still won’t tell his or her
partner, you are within your legal right to tell the
innocent third party.
The name of the source patient is always
protected.
• Partner notification and reportable illnesses are an
example of one of the few times that the patients
autonomy can be superseded because of the
necessity of protecting others.
• Tuberculosis has special reporting and public health
issues.
• In addition to doing contact tracing of the contacts
in order to do (purified protein derivative PPD)
testing, there is the special issue of incarceration
for tuberculosis.
• Patients with tuberculosis should be isolated for
about two weeks, which is approximately the
amount of time that is takes for sputum to become
negative for acid-fast bacilli.
• lf a patient refuses to take anti-tuberculosis
therapy, physicians have the option of incarcerating
the patient to prevent them from the spread of the
disease.
• This is only for those who still have positive stains
of their them sputum for acid fast bacilli.
HIV-Related Issues:
• Confidentiality:
• As with all medical information there is a
presumption of confidentiality on the part of the
physician.
• When a patient enters the hospital or other health-
care facility there is general consent given that
allows the routine testing of blood for chemistry
and hematology and so on.
• When a patient signs a release to distribute or
transmit medical information there is an additional
consent required for HIV or AIDS-related
information.
• For example, a woman comes at 10 weeks of
pregnancy for prenatal care. She has a history of
sexually transmitted diseases such as gonorrhea.
• You offer HIV testing, which the patient refuses, as a
routine part of prenatal care.
• She returns at 14 and l8 weeks of pregnancy but is still
refusing because of anxiety that she may be positive.
• You inform the patient that there are medications that
can reduce transmission from mother to child to less
than 2 percent.
• She persists in her refusal. What should you do now?
• Answer:
• Although there are medications to prevent
transmission of HIV to the fetus during pregnancy,
you cannot compel mandatory testing of pregnant
women.
• The woman has the right to refuse testing as well
as to refuse anti retrovirals.
• The autonomy of the mother is legally
superior to beneficence for the fetus.
• A woman has the right to refuse HIV testing in
pregnancy, to refuse antiretroviral medications
in pregnancy, and to refuse a C-section even if it
will markedly benefit the child.
PARTNER NOTIFICATION:
• The high level of confidentiality concerning HIV can
only be breached under very specific circumstances
such as when the health of a third party is at risk.
• A circumstance such as this would be when an HIV-
positive person has a sexual or needle-sharing partner
that is at risk.
• The method of notification follows the steps of first
counselling a patient to notify his partners voluntarily.
• This would be ideal and follows the general theme of
USMLE, which is to first answer "encourage
discussions” when listed as one of the choices.
• If the patient is either emotionally unable or
unwilling to notify their partners the next step is to
notify the Department of Health to start
the process of contact tracing.
• The health department interviews the patient and
attempts to construct a list of partners in order to
notify them.
HIV-POSITIVE HEATTH-CARE
WORKERS
• There is no duty on the part of an HlV-positive
health care worker to inform his patient of his HIV
status.
•Universal precautions are supposed to be
maintained. These should protect the patients.
• An HIV-positive physician who practices high-risk
surgical and obstetric procedures is expected to
maintain precautions to protect the patients from
transmission.
REFUSAl TO TREAT HIV-POSITIVE
PATIENTS:
• It is ethically unacceptable to refuse to treat HlV or
take care of HlV, positive patients simply because
they are HIV-positive.
• lf you have a physician to whom you refer patients
for various treatments, it would not be ethical for
that person to discriminate only on the basis of the
patient being HIV-positive.
• On the other hand, you cannot compel a physician
to take over the management of any patient if the
physician doesn’t want to do so.
Sexually Transmitted
Diseases (STD):
• The ethical issues surrounding STDs have to do with
partner notification, contact tracing, and reporting
requirements.
• Although reporting requirements vary some what from
state to state, certain diseases are reportable nationally
such as syphilis, gonorrhea, and AIDS.
• Herpes simplex is generally not reportable and there is
no contact tracing for herpes.
• Contac tracing is predominantly used to interrupt a
cycle of transmission.
• Contact tracing is a public health practice that health
departments use to identify and notify people who
have been exposed to someone with an infectious
• Herpes cannot be eradicated from the body; hence
there is no utility in treating the partner.
• Gonorrhea ands syphilis, however can be
asymptomatically carried by the contacts of our
patients and they can be transmitted to additional
partners even if the source patient is
asymptomatic.
• In addition, syphilis and gonorrhea can be
eradicated (cured) with treatment.
• For example,
• Bob is a 32-year-old man in your clinic being
treated for primary syphilis. He is very embarrassed
about his diagnosis and he asks you if his condition
will be kept confidential. What should you tell him?
• Answer:
• If there is a choice that says "encourage him to
notify his partners" or "ask if he has already told his
contacts“ that should be the first thing to do

Mais conteúdo relacionado

Semelhante a 6. Reporting Communicable Diseases.pptx

3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx
3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx
3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptxDr. Ayub Abdulkadir Abdi
 
HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)ariannejassy07
 
Oral PrEP Webinar Session I - Lesotho
Oral PrEP Webinar Session I - LesothoOral PrEP Webinar Session I - Lesotho
Oral PrEP Webinar Session I - LesothoJSI
 
AIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptxAIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptxaiabkkau
 
7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptxyakemichael
 
Hiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implicationsHiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implicationsDr Sandeep Kumar Giri
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSDfreespirit7
 
Counselling HIV/ AIDS patient
Counselling HIV/ AIDS patient Counselling HIV/ AIDS patient
Counselling HIV/ AIDS patient Qurrot Ulain Taher
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit1901600146
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareCHC Connecticut
 
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptxDr. Ayub Abdulkadir Abdi
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsCHC Connecticut
 
2 hiv a communicable disease
2 hiv  a communicable disease2 hiv  a communicable disease
2 hiv a communicable diseaseMahendra Poudel
 

Semelhante a 6. Reporting Communicable Diseases.pptx (20)

Article
ArticleArticle
Article
 
3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx
3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx
3. Relationship b.w Doctor-Patient & Doctor-Doctor.pptx
 
HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)
 
Oral PrEP Webinar Session I - Lesotho
Oral PrEP Webinar Session I - LesothoOral PrEP Webinar Session I - Lesotho
Oral PrEP Webinar Session I - Lesotho
 
AIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptxAIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptx
 
7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx7. When to start ART (Eligibility)Rev.pptx
7. When to start ART (Eligibility)Rev.pptx
 
HIV Update 2017
HIV Update  2017 HIV Update  2017
HIV Update 2017
 
Hiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implicationsHiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implications
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSD
 
presentation-4.pptx
presentation-4.pptxpresentation-4.pptx
presentation-4.pptx
 
Hiv and Aids.pptx
Hiv and Aids.pptxHiv and Aids.pptx
Hiv and Aids.pptx
 
Hiv, aids and std's
Hiv, aids and std'sHiv, aids and std's
Hiv, aids and std's
 
Counselling HIV/ AIDS patient
Counselling HIV/ AIDS patient Counselling HIV/ AIDS patient
Counselling HIV/ AIDS patient
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary Care
 
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx
2. Autonomy, Competence, Minor, Consent, & Confidentiality.pptx
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key Populations
 
2 hiv a communicable disease
2 hiv  a communicable disease2 hiv  a communicable disease
2 hiv a communicable disease
 
STD-TRI.pptx
STD-TRI.pptxSTD-TRI.pptx
STD-TRI.pptx
 

Mais de Dr. Ayub Abdulkadir Abdi

Mais de Dr. Ayub Abdulkadir Abdi (11)

Cardio-Hepatic Syndrome.pptx
Cardio-Hepatic Syndrome.pptxCardio-Hepatic Syndrome.pptx
Cardio-Hepatic Syndrome.pptx
 
Musculoskeletal X - Ray.pptx
Musculoskeletal X - Ray.pptxMusculoskeletal X - Ray.pptx
Musculoskeletal X - Ray.pptx
 
A summary of skeletal muscle contraction and relaxation.pdf
A summary of skeletal muscle contraction and relaxation.pdfA summary of skeletal muscle contraction and relaxation.pdf
A summary of skeletal muscle contraction and relaxation.pdf
 
Lymph node, Lump, & Ulcer Examination.pptx
Lymph node, Lump, & Ulcer Examination.pptxLymph node, Lump, & Ulcer Examination.pptx
Lymph node, Lump, & Ulcer Examination.pptx
 
9. Medical Research.pptx
9. Medical Research.pptx9. Medical Research.pptx
9. Medical Research.pptx
 
7. Dying & Euthanasia.pptx
7. Dying & Euthanasia.pptx7. Dying & Euthanasia.pptx
7. Dying & Euthanasia.pptx
 
8. Children, elder, spousal Abuse.pptx
8. Children, elder, spousal Abuse.pptx8. Children, elder, spousal Abuse.pptx
8. Children, elder, spousal Abuse.pptx
 
5. Organ Donation & Transplantation.pptx
5. Organ Donation & Transplantation.pptx5. Organ Donation & Transplantation.pptx
5. Organ Donation & Transplantation.pptx
 
10. Ethics in female reproductive.pptx
10. Ethics in female reproductive.pptx10. Ethics in female reproductive.pptx
10. Ethics in female reproductive.pptx
 
4. Medical Malpractice and Medical Records.pptx
4. Medical Malpractice and Medical Records.pptx4. Medical Malpractice and Medical Records.pptx
4. Medical Malpractice and Medical Records.pptx
 
1. Introduction To Ethics.pptx
1. Introduction To Ethics.pptx1. Introduction To Ethics.pptx
1. Introduction To Ethics.pptx
 

Último

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Último (20)

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

6. Reporting Communicable Diseases.pptx

  • 1. 6. Reporting Communicable Disease: Dr. Ayub Abdulkadir (Dr. Alto) Medical Ethics
  • 2. Reportable illness: • Physicians and laboratories are mandated to report a number of medical illnesses. The main purpose in reporting illnesses is both epidemiologic as well as to interrupt the spread of certain communicable diseases. • The illnesses that are always reportable include: 1. AIDS. 2. Syphilis. 3. Tuberculosis. 4. Gonorrhea.
  • 3. • and all of the childhood diseases such as: 1. Measles. 2. Mumps. 3. Rubella. 4. Pertussis. • These diseases are reportable by somebody, not necessarily the physician. • Physicians are always legally protected for participating in partner notification. • In general, the health department performs the majority of contact-tracing events as well as notifying those that have been in close contact of the possibility of infection.
  • 4. • Partner notification exists for diseases such as HIV/AIDS, syphilis, gonorrhea, and tuberculosis. • In addition, the health department can incarcerate (jail) patients with tuberculosis to prevent the spread of disease. • If a patient won’t tell his or her partner, then you must answer that you must follow your duty to report. • If the source patient still won’t tell his or her partner, you are within your legal right to tell the innocent third party. The name of the source patient is always protected.
  • 5. • Partner notification and reportable illnesses are an example of one of the few times that the patients autonomy can be superseded because of the necessity of protecting others. • Tuberculosis has special reporting and public health issues. • In addition to doing contact tracing of the contacts in order to do (purified protein derivative PPD) testing, there is the special issue of incarceration for tuberculosis.
  • 6. • Patients with tuberculosis should be isolated for about two weeks, which is approximately the amount of time that is takes for sputum to become negative for acid-fast bacilli. • lf a patient refuses to take anti-tuberculosis therapy, physicians have the option of incarcerating the patient to prevent them from the spread of the disease. • This is only for those who still have positive stains of their them sputum for acid fast bacilli.
  • 7. HIV-Related Issues: • Confidentiality: • As with all medical information there is a presumption of confidentiality on the part of the physician. • When a patient enters the hospital or other health- care facility there is general consent given that allows the routine testing of blood for chemistry and hematology and so on. • When a patient signs a release to distribute or transmit medical information there is an additional consent required for HIV or AIDS-related information.
  • 8. • For example, a woman comes at 10 weeks of pregnancy for prenatal care. She has a history of sexually transmitted diseases such as gonorrhea. • You offer HIV testing, which the patient refuses, as a routine part of prenatal care. • She returns at 14 and l8 weeks of pregnancy but is still refusing because of anxiety that she may be positive. • You inform the patient that there are medications that can reduce transmission from mother to child to less than 2 percent. • She persists in her refusal. What should you do now?
  • 9. • Answer: • Although there are medications to prevent transmission of HIV to the fetus during pregnancy, you cannot compel mandatory testing of pregnant women. • The woman has the right to refuse testing as well as to refuse anti retrovirals. • The autonomy of the mother is legally superior to beneficence for the fetus. • A woman has the right to refuse HIV testing in pregnancy, to refuse antiretroviral medications in pregnancy, and to refuse a C-section even if it will markedly benefit the child.
  • 10. PARTNER NOTIFICATION: • The high level of confidentiality concerning HIV can only be breached under very specific circumstances such as when the health of a third party is at risk. • A circumstance such as this would be when an HIV- positive person has a sexual or needle-sharing partner that is at risk. • The method of notification follows the steps of first counselling a patient to notify his partners voluntarily. • This would be ideal and follows the general theme of USMLE, which is to first answer "encourage discussions” when listed as one of the choices.
  • 11. • If the patient is either emotionally unable or unwilling to notify their partners the next step is to notify the Department of Health to start the process of contact tracing. • The health department interviews the patient and attempts to construct a list of partners in order to notify them.
  • 12. HIV-POSITIVE HEATTH-CARE WORKERS • There is no duty on the part of an HlV-positive health care worker to inform his patient of his HIV status. •Universal precautions are supposed to be maintained. These should protect the patients. • An HIV-positive physician who practices high-risk surgical and obstetric procedures is expected to maintain precautions to protect the patients from transmission.
  • 13.
  • 14. REFUSAl TO TREAT HIV-POSITIVE PATIENTS: • It is ethically unacceptable to refuse to treat HlV or take care of HlV, positive patients simply because they are HIV-positive. • lf you have a physician to whom you refer patients for various treatments, it would not be ethical for that person to discriminate only on the basis of the patient being HIV-positive. • On the other hand, you cannot compel a physician to take over the management of any patient if the physician doesn’t want to do so.
  • 15. Sexually Transmitted Diseases (STD): • The ethical issues surrounding STDs have to do with partner notification, contact tracing, and reporting requirements. • Although reporting requirements vary some what from state to state, certain diseases are reportable nationally such as syphilis, gonorrhea, and AIDS. • Herpes simplex is generally not reportable and there is no contact tracing for herpes. • Contac tracing is predominantly used to interrupt a cycle of transmission. • Contact tracing is a public health practice that health departments use to identify and notify people who have been exposed to someone with an infectious
  • 16. • Herpes cannot be eradicated from the body; hence there is no utility in treating the partner. • Gonorrhea ands syphilis, however can be asymptomatically carried by the contacts of our patients and they can be transmitted to additional partners even if the source patient is asymptomatic. • In addition, syphilis and gonorrhea can be eradicated (cured) with treatment.
  • 17. • For example, • Bob is a 32-year-old man in your clinic being treated for primary syphilis. He is very embarrassed about his diagnosis and he asks you if his condition will be kept confidential. What should you tell him? • Answer: • If there is a choice that says "encourage him to notify his partners" or "ask if he has already told his contacts“ that should be the first thing to do